On June 19, the highly anticipated CPhI China 2024 (Chemical Pharmaceutical Ingredient China) opened grandly in Shanghai. Pioneers from the pharmaceutical industry from all over the world gathered in Shanghai, to explore cutting-edge technologies in the industry and discuss exchanges and cooperation. As a leading company in the domestic chemical raw materials segment, Keyuan Pharma (stock code: 301281.SZ) was invited to participate in the exhibition again, showing the world its outstanding scientific research strength and forward-looking international layout, and once again took a new step in its internationalization strategy.
Before the opening of the exhibition, Hongsheng Jiang, Chairman and President of Keyuan Pharma, and the international marketing team held an international VIP customer forum to communicate with partners from all over the world, aiming to strengthen communication and contact with partners, deeply explore industry development trends, grasp the pulse of industry development, exchange scientific research results and products, and seek new opportunities for cooperation.
At the exhibition, Keyuan Pharma booth became the focus of everyone's attention. The overall color of technology blue and medical white was neat and bright, the core products were neatly displayed, and the company's advantages were clearly prominent, attracting many new and old customers to stop and watch and consult. The scene was crowded and the atmosphere was active.
As a company committed to the global pharmaceutical and health industry, Keyuan Pharma has always regarded internationalization as one of the important strategies for the company's development. All products have passed the China GMP certification, and core products have successively passed the official pharmaceutical certifications of many countries, such as the EU EDQM, the US FDA, the Japanese PMDA, and the Korean MFDS, laying a solid foundation for the company's internationalization strategy.
Over the years, Keyuan Pharma has continuously increased its efforts to expand in overseas markets and actively sought cooperation with internationally renowned companies. In this exhibition, Keyuan Pharma had in-depth exchanges with many internationally renowned companies and reached a number of strategic cooperation intentions, which will promote the company's further development in R&D, production, sales, etc., further enhance Keyuan Pharma's international influence and competitiveness in the global pharmaceutical market, and inject new impetus into the company's internationalization strategy.
Connect the world and outline the future. Keyuan Pharma will take a more determined step and a more open attitude, adhere to the mission of protecting life and health with digital medicine, continue to deepen the pharmaceutical industry, actively expand the international market, and contribute more to the development of the global pharmaceutical and health industry!